Optimizing Non-statin Agents for ASCVD

Part of paid clinical trials in Austin, Texas.

Sponsor
University of Texas at Austin
Study ID
NCT07464574
Status
Recruiting
Apply to this trial

Conditions

  • ASCVD Management

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Pharmacy Intern Counseling — BEHAVIORAL
    The research intervention consists of outreach conducted by a Texas-licensed pharmacist intern under the supervision of CuC-employed pharmacists. Eligible patients will be contacted by a student pharmacist after the clinical pharmacists' appointment (described above in the standard of care) using CuC's RingCentral telehealth system. During this outreach, student pharmacists will review current lipid-lowering therapies, medication adherence, education about lipid-lowering therapies, and review of labs. Student pharmacists will not make independent prescribing or care decisions. All prescribing authority and therapeutic adjustments remain under the direction of CuC-employed pharmacists in accordance with the standard operating procedures. Patients will be informed about the research project during the outreach call or during a separate call dedicated to recruitment prior to the outreach call. Informed consent will be sent and obtained via either the EHR messaging system (MyChart) or text

Study Details

* The purpose of the study is to improve care for patients with high cholesterol. * If you choose to join the study, you will be asked to answer a phone call from study personnel. They will help you coordinate follow up appointments, review your medications and lab with you, and answer any questions you have about your medications. You will also continue to be seen by a clinical pharmacy team member. Your cholesterol medications may change to better lower your cholesterol. We will collect information about your visits, medicines, and cholesterol levels for 6 months. * If you choose not to participate, you will receive the same information and treatment at your next scheduled visit. You will receive the same care regardless of choosing to participate in the study. * Participation might involve a very low risk of some loss of privacy. There is low risk that someone outside the research study could see information about you. * A possible benefit is lower cholesterol. * Taking part in this research study is your choice. You do not have to participate, and you can stop at any time without any penalty.

Key Dates

Start date
Jan 16, 2026
Status verified
Mar 2026
Primary completion
Dec 31, 2026
Completion
May 1, 2027

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Enrolled Patients
    Adult patients (\>18 years) who have seen a CommUnityCare provider in the previous 12 months at time of enrollment, who have a documented history of clinical ASCVD, and are not achieving LDL targets (either \<55 or \<70 mg/dL based on risk factors)

Primary Outcome Measure

Percentage of patients at LDL target [ Time Frame: 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
CommUnityCare Health CentersAustinTexas78741
Morgan Stewart, PharmD
[email protected]
512-978-9096
Madison Tran (SUB_INVESTIGATOR)
Khue (Chloe) Dao (SUB_INVESTIGATOR)
Kathryn Lin, PharmD (SUB_INVESTIGATOR)

Find similar trials in Austin, TX

By research site
CommUnityCare Health Centers· Austin, TX

Related Studies